, Volume 46, Issue 9, pp 755–758 | Cite as

HTLV-I carrier with unusual brain MR imaging findings

  • Shinsaku Yata
  • Toshihide OgawaEmail author
  • Shuji Sugihara
  • Eiji Matsusue
  • Shinya Fujii
  • Toshibumi Kinoshita
Diagnostic Neuroradiology


We describe unusual brain MR imaging findings in a patient who is an HTLV-I carrier without myelopathy. T2-weighted MR images showed hyperintense signal abnormalities in the pyramidal tract, superior and middle cerebellar peduncles, and decussation of the superior cerebellar peduncles, in addition to subcortical white matter involvement. Diffusion-weighted images also showed hyperintense signal abnormalities in the same regions by T2 shine-through effect.


HTLV-1 carrier Brain Pyramidal tract Magnetic resonance imaging 


  1. 1.
    Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407–410CrossRefPubMedGoogle Scholar
  2. 2.
    Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-1 associated myelopathy. A new clinical entity. Lancet 1:1031-1032CrossRefGoogle Scholar
  3. 3.
    Izumo S, Umehara F, Osame M (2000) HTLV-I-associated myelopathy. Neuropathology 20 [Suppl]:S65–68Google Scholar
  4. 4.
    Iwasaki Y (1990) Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 96:103–123CrossRefPubMedGoogle Scholar
  5. 5.
    Ogata A, Nagashima K, Tashiro K, Miyakawa A, Mikuni C (1993) MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry 56:194–196PubMedGoogle Scholar
  6. 6.
    Alcindor F, Valderrma R, Canavaggio M, Lee H, Katz A, Montesinos C, Madrid RE, Merino RR, Pipia PA (1992) Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies. Neuroradiology 35:69–74PubMedGoogle Scholar
  7. 7.
    Shakudo M, Inoue Y, Tsutada T (1999) HTLV-I-associated myelopathy: acute progression and atypical MR findings. AJNR Am J Neuroradiol 20:1417–1421PubMedGoogle Scholar
  8. 8.
    Kira J, Fujihara K, Itoyama Y, Goto I, Hasuo K (1991) Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 106:41–49CrossRefPubMedGoogle Scholar
  9. 9.
    Fukushima T, Ikeda T, Uyama E, Uchino M, Okabe H, Ando M (1994) Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-1 associated myelopathy (HAM). J Neurol Sci 126:30–39CrossRefPubMedGoogle Scholar
  10. 10.
    Kuroda Y, Matsui M, Yukitake M, Kurohara K, Takashima H, Takashima Y, Endo C, Kato A, Mihara F (1995) Assessment of MRI criteria for MS in Japanese MS and HAM/TSP. Neurology 45:30–33PubMedGoogle Scholar
  11. 11.
    Konagaya M, Iida M (1991) A case of HTLV-I associated myelopathy with diffuse white matter lesion of the frontal lobe and continuous lesion of the pyramidal tract on cranial MRI. Rinsho Shinkeigaku 31:875–877PubMedGoogle Scholar
  12. 12.
    Iroi A, Miyashita N, Nakamura S, Ohizumi H, Mizuno Y (2000) A patient with marked immunodeficiency in an HTLV-I carrier: a case report. Rinsho Shinkeigaku 40:135–139PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Shinsaku Yata
    • 1
  • Toshihide Ogawa
    • 1
    Email author
  • Shuji Sugihara
    • 1
  • Eiji Matsusue
    • 1
  • Shinya Fujii
    • 1
  • Toshibumi Kinoshita
    • 1
  1. 1.Division of Radiology, Department of Pathophysiological and Therapeutic ScienceFaculty of Medicine, Tottori UniversityYonagoJapan

Personalised recommendations